BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 26150656)

  • 1. Effects of neutralizing antibodies on escape from CD8+ T-cell responses in HIV-1 infection.
    Wikramaratna PS; Lourenço J; Klenerman P; Pybus OG; Gupta S
    Philos Trans R Soc Lond B Biol Sci; 2015 Aug; 370(1675):. PubMed ID: 26150656
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Viremia control despite escape from a rapid and potent autologous neutralizing antibody response after therapy cessation in an HIV-1-infected individual.
    Montefiori DC; Altfeld M; Lee PK; Bilska M; Zhou J; Johnston MN; Gao F; Walker BD; Rosenberg ES
    J Immunol; 2003 Apr; 170(7):3906-14. PubMed ID: 12646660
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biphasic CD8+ T-Cell Defense in Simian Immunodeficiency Virus Control by Acute-Phase Passive Neutralizing Antibody Immunization.
    Iseda S; Takahashi N; Poplimont H; Nomura T; Seki S; Nakane T; Nakamura M; Shi S; Ishii H; Furukawa S; Harada S; Naruse TK; Kimura A; Matano T; Yamamoto H
    J Virol; 2016 Jul; 90(14):6276-6290. PubMed ID: 27122584
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Loss of viral control in early HIV-1 infection is temporally associated with sequential escape from CD8+ T cell responses and decrease in HIV-1-specific CD4+ and CD8+ T cell frequencies.
    Oxenius A; Price DA; Trkola A; Edwards C; Gostick E; Zhang HT; Easterbrook PJ; Tun T; Johnson A; Waters A; Holmes EC; Phillips RE
    J Infect Dis; 2004 Aug; 190(4):713-21. PubMed ID: 15272399
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Whole genome deep sequencing of HIV-1 reveals the impact of early minor variants upon immune recognition during acute infection.
    Henn MR; Boutwell CL; Charlebois P; Lennon NJ; Power KA; Macalalad AR; Berlin AM; Malboeuf CM; Ryan EM; Gnerre S; Zody MC; Erlich RL; Green LM; Berical A; Wang Y; Casali M; Streeck H; Bloom AK; Dudek T; Tully D; Newman R; Axten KL; Gladden AD; Battis L; Kemper M; Zeng Q; Shea TP; Gujja S; Zedlack C; Gasser O; Brander C; Hess C; Günthard HF; Brumme ZL; Brumme CJ; Bazner S; Rychert J; Tinsley JP; Mayer KH; Rosenberg E; Pereyra F; Levin JZ; Young SK; Jessen H; Altfeld M; Birren BW; Walker BD; Allen TM
    PLoS Pathog; 2012; 8(3):e1002529. PubMed ID: 22412369
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of CD8
    Arcia D; Acevedo-Sáenz L; Rugeles MT; Velilla PA
    Viral Immunol; 2017; 30(1):3-12. PubMed ID: 27805477
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased frequencies of CD8
    Palmer CD; Romero-Tejeda M; Scully EP; Lockhart A; Seaman MS; Goldenthal A; Piechocka-Trocha A; Walker BD; Chibnik LB; Jost S; Porichis F
    J Int AIDS Soc; 2016; 19(1):21136. PubMed ID: 27938646
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Non-cytolytic CD8 T-cell anti-HIV responses in primary HIV-1 infection.
    Mackewicz CE; Yang LC; Lifson JD; Levy JA
    Lancet; 1994 Dec; 344(8938):1671-3. PubMed ID: 7996961
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CD8+ T Cell Breadth and Ex Vivo Virus Inhibition Capacity Distinguish between Viremic Controllers with and without Protective HLA Class I Alleles.
    Koofhethile CK; Ndhlovu ZM; Thobakgale-Tshabalala C; Prado JG; Ismail N; Mncube Z; Mkhize L; van der Stok M; Yende N; Walker BD; Goulder PJR; Ndung'u T
    J Virol; 2016 Aug; 90(15):6818-6831. PubMed ID: 27194762
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HIV/AIDS Vaccine Candidates Based on Replication-Competent Recombinant Poxvirus NYVAC-C-KC Expressing Trimeric gp140 and Gag-Derived Virus-Like Particles or Lacking the Viral Molecule B19 That Inhibits Type I Interferon Activate Relevant HIV-1-Specific B and T Cell Immune Functions in Nonhuman Primates.
    García-Arriaza J; Perdiguero B; Heeney JL; Seaman MS; Montefiori DC; Yates NL; Tomaras GD; Ferrari G; Foulds KE; Roederer M; Self SG; Borate B; Gottardo R; Phogat S; Tartaglia J; Barnett SW; Burke B; Cristillo AD; Weiss DE; Lee C; Kibler KV; Jacobs BL; Wagner R; Ding S; Pantaleo G; Esteban M
    J Virol; 2017 May; 91(9):. PubMed ID: 28179536
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Conformational Epitope-Specific Broadly Neutralizing Plasma Antibodies Obtained from an HIV-1 Clade C-Infected Elite Neutralizer Mediate Autologous Virus Escape through Mutations in the V1 Loop.
    Patil S; Kumar R; Deshpande S; Samal S; Shrivastava T; Boliar S; Bansal M; Chaudhary NK; Srikrishnan AK; Murugavel KG; Solomon S; Simek M; Koff WC; Goyal R; Chakrabarti BK; Bhattacharya J
    J Virol; 2016 Jan; 90(7):3446-57. PubMed ID: 26763999
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Selective escape from CD8+ T-cell responses represents a major driving force of human immunodeficiency virus type 1 (HIV-1) sequence diversity and reveals constraints on HIV-1 evolution.
    Allen TM; Altfeld M; Geer SC; Kalife ET; Moore C; O'sullivan KM; Desouza I; Feeney ME; Eldridge RL; Maier EL; Kaufmann DE; Lahaie MP; Reyor L; Tanzi G; Johnston MN; Brander C; Draenert R; Rockstroh JK; Jessen H; Rosenberg ES; Mallal SA; Walker BD
    J Virol; 2005 Nov; 79(21):13239-49. PubMed ID: 16227247
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A strongly selected mutation in the HIV-1 genome is independent of T cell responses and neutralizing antibodies.
    Liu D; Wang C; Hora B; Zuo T; Goonetilleke N; Liu MKP; Berrong M; Ferrari G; McMichael AJ; Bhattacharya T; Perelson AS; Gao F
    Retrovirology; 2017 Oct; 14(1):46. PubMed ID: 29017536
    [TBL] [Abstract][Full Text] [Related]  

  • 14. De novo generation of escape variant-specific CD8+ T-cell responses following cytotoxic T-lymphocyte escape in chronic human immunodeficiency virus type 1 infection.
    Allen TM; Yu XG; Kalife ET; Reyor LL; Lichterfeld M; John M; Cheng M; Allgaier RL; Mui S; Frahm N; Alter G; Brown NV; Johnston MN; Rosenberg ES; Mallal SA; Brander C; Walker BD; Altfeld M
    J Virol; 2005 Oct; 79(20):12952-60. PubMed ID: 16188997
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HIV replication leads to skewed maturation of CD8-positive T-cell responses in infected children.
    Montesano C; Anselmi A; Palma P; Bernardi S; Cicconi R; Mattei M; Castelli-Gattinara G; Ciccozzi M; Colizzi V; Amicosante M
    New Microbiol; 2010 Oct; 33(4):303-9. PubMed ID: 21213588
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Short communication: characteristics of effective immune control of simian/human immunodeficiency virus in pigtail macaques.
    Stratov I; Dale CJ; Chea S; Montefiori DC; De Rose R; Reece JC; Kent SJ
    AIDS Res Hum Retroviruses; 2006 Jan; 22(1):27-32. PubMed ID: 16438642
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HIV-1 resistance to neutralizing antibodies: Determination of antibody concentrations leading to escape mutant evolution.
    Magnus C; Reh L; Trkola A
    Virus Res; 2016 Jun; 218():57-70. PubMed ID: 26494166
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Investigating the Consequences of Interference between Multiple CD8+ T Cell Escape Mutations in Early HIV Infection.
    Garcia V; Feldman MW; Regoes RR
    PLoS Comput Biol; 2016 Feb; 12(2):e1004721. PubMed ID: 26829720
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Time Intervals in Sequence Sampling, Not Data Modifications, Have a Major Impact on Estimates of HIV Escape Rates.
    Ganusov VV
    Viruses; 2018 Feb; 10(3):. PubMed ID: 29495443
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunodominance of HIV-1-specific CD8(+) T-cell responses in acute HIV-1 infection: at the crossroads of viral and host genetics.
    Lichterfeld M; Yu XG; Le Gall S; Altfeld M
    Trends Immunol; 2005 Mar; 26(3):166-71. PubMed ID: 15745859
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.